Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab
Links shared publicly online about this topic.
- 0total visits
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab
The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side e
View full resource at medicalnewstoday.com
Tags: Cancer, Colorectal Cancer Medication, Phase 2 Clinical Trial, Avastin, Oncology, Radiation
Most Recently Shared on December 20, 2011 at 8:05 am By:
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab http://t.co/pKBM03lh #entnews
Also Shared By:
Advertisement
MNT Cancer News
@mnt_cancer
Phase 2 Trial Finds Spread Of Nasopharyngeal Carcinoma Is Reduced By Bevacizumab http://t.co/x9DNvHxG #cancer
1 year ago...